Loading…
SOPHiA GENETICS SA is projected to rise to $6.32 by 2027, a +24% move from its current price of $5.08. SOPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.94 | $5.08 | $5.23 | +0.05% |
| May 30 | $4.89 | $5.09 | $5.29 | +0.10% |
| May 31 | $4.85 | $5.09 | $5.34 | +0.15% |
| Jun 1 | $4.82 | $5.09 | $5.38 | +0.20% |
| Jun 2 | $4.79 | $5.09 | $5.42 | +0.26% |
| Jun 3 | $4.76 | $5.10 | $5.45 | +0.31% |
| Jun 4 | $4.74 | $5.10 | $5.49 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.74 | $5.10 | $5.49 | +0.36% |
| Week 2 | $4.61 | $5.12 | $5.68 | +0.72% |
| Week 3 | $4.52 | $5.13 | $5.83 | +1.08% |
| Week 4 | $4.45 | $5.15 | $5.97 | +1.44% |
| Week 5 | $4.39 | $5.17 | $6.09 | +1.80% |
| Week 6 | $4.34 | $5.19 | $6.21 | +2.16% |
| Week 7 | $4.29 | $5.21 | $6.33 | +2.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SOPHiA GENETICS SA is a healthcare technology company that operates as cloud-native software in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom.
The company was incorporated in 2011 and is based in Rolle, Switzerland.
SOPHiA GENETICS SA (SOPH) is a healthcare software company currently trading at $4.88 with a market cap of $350.34M and a rank of 3362.
The current price is $4.88, and the market cap is $350.34M, with a rank of 3362.
Forecast data for 2026 show an average price of $4.88 with a min of $4.10 and a max of $6.71; sentiment is NEUTRAL. From 2027 onward, the forecast turns bullish with progressively higher averages and ROIs through 2050, indicating potential upside over the long term.
The long-range outlook suggests meaningful upside beyond 2026, with bullish sentiment expected in later years.
A major floor 19.3% below — a decisive break under it would weaken the trend.
The nearest floor, 11.2% below — buyers have tended to step in here.
The nearest ceiling, 6.3% above — a clean break opens room to run.
A major ceiling 15.9% above — clearing it would confirm fresh momentum.
Key SOPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SOPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.98 | Buy | $4.97 | Buy |
| MA 10 | $4.81 | Buy | $4.92 | Buy |
| MA 20 | $4.97 | Buy | $4.92 | Buy |
| MA 50 | $4.95 | Buy | $4.91 | Buy |
| MA 100 | $4.91 | Buy | $4.82 | Buy |
| MA 200 | $4.53 | Buy | $4.55 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.33 | Neutral |
| Stoch RSI (14) | 71.60 | Neutral |
| CCI (20) | 33.63 | Neutral |
| Williams %R (14) | -35.96 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -1.36 | Sell |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 64.04 | Neutral |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 66.15 | Neutral |
| Momentum (10) | 0.45 | Buy |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 5.08 | Sell |
| ADX (14) | 10.92 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The SMA50 is $4.94 and the SMA200 is $4.51, relative to the current price of $4.88.
Support is at $4.51 and resistance at $5.40, framing a near-term path. The 30-day range is $4.04 to $5.90, indicating a modestly wide trading band.
Annualized volatility is 60%., indicating elevated price fluctuations around the 30-day window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.10 | $5.08 | $7.00 | 0% | Neutral | |
| $5.00 | $6.32 | $8.46 | +24% | Bullish | |
| $5.93 | $7.70 | $10.69 | +52% | Bullish | |
| $6.71 | $8.92 | $12.74 | +76% | Bullish | |
| $6.99 | $9.48 | $13.87 | +87% | Bullish | |
| $7.38 | $10.20 | $15.25 | +101% | Bullish | |
| $7.22 | $10.16 | $15.47 | +100% | Bullish | |
| $7.53 | $10.77 | $16.69 | +112% | Bullish | |
| $9.58 | $13.91 | $21.90 | +174% | Bullish | |
| $10.43 | $15.37 | $24.57 | +203% | Bullish | |
| $12.96 | $20.46 | $34.78 | +303% | Bullish | |
| $23.63 | $41.95 | $78.10 | +726% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.10 | $5.08 | $5.96 | +0.00% |
| June 2026 | $4.42 | $5.19 | $6.25 | +2.22% |
| July 2026 | $4.49 | $5.32 | $6.49 | +2.48% |
| August 2026 | $4.38 | $5.23 | $6.44 | -1.78% |
| September 2026 | $4.38 | $5.25 | $6.52 | +0.40% |
| October 2026 | $4.57 | $5.51 | $6.90 | +4.96% |
| November 2026 | $4.63 | $5.60 | $7.06 | +1.69% |
| December 2026 | $4.53 | $5.51 | $7.00 | -1.57% |
Click any year to see its month-by-month SOPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SOPH price prediction for 2026 points to an average of $5.08 (low $4.10, high $7.00) — a potential gain of 0% on today's $5.08. A consolidation phase looks the most probable path here.
In 2027, SOPH is projected to trade between $5.00 and $8.46, averaging $6.32 — a potential gain of +24% from today's $5.08. That is up +24% on the projected 2026 average. Momentum favours further upside here.
SOPHiA GENETICS SA's 2028 outlook centres on $7.70, within a $5.93 to $10.69 range. That is up +22% on the projected 2027 average. That marks a +52% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, SOPH could reach as high as $12.74, with a base case around $8.92 and support toward $6.71 — roughly +76% from $5.08. Momentum favours further upside here.
Expect SOPH to range from $6.99 to $13.87 through 2030. The $9.48 average target implies a +87% move from current prices. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The SOPH price prediction for 2031 points to an average of $10.20 (low $7.38, high $15.25) — a potential gain of +101% on today's $5.08. Momentum favours further upside here.
In 2032, SOPH is projected to trade between $7.22 and $15.47, averaging $10.16 — a potential gain of +100% from today's $5.08. That is 0% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
SOPHiA GENETICS SA's 2033 outlook centres on $10.77, within a $7.53 to $16.69 range. That is up +6% on the projected 2032 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2034, SOPH could reach as high as $21.90, with a base case around $13.91 and support toward $9.58 — roughly +174% from $5.08. Buyers look set to stay in control over this stretch.
Expect SOPH to range from $10.43 to $24.57 through 2035. The $15.37 average target implies a +203% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The SOPH price prediction for 2040 points to an average of $20.46 (low $12.96, high $34.78) — a potential gain of +303% on today's $5.08. Buyers look set to stay in control over this stretch.
In 2050, SOPH is projected to trade between $23.63 and $78.10, averaging $41.95 — a potential gain of +726% from today's $5.08. That is up +105% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SOPH today (≈ 196.850394 SOPH) could be worth
$8,258.8
+$7,258.8 (+726%) by 2050 · US Dollar
Based on the average projected SOPH price of $41.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SOPHwould be worth at today's price.
$1,000 invested in SOPH on May 27, 2025 (≈ 344.827575 SOPH) would be worth
$1,751.72
+$751.72 (+75.2%) today · 1.75× · US Dollar
Based on a SOPH entry price of $2.9 vs. today's $5.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.87 | $1,043.12 | +4.3% |
| 1 month ago | $4.86 | $1,045.27 | +4.5% |
| 3 months ago | $4.57 | $1,111.6 | +11.2% |
| 6 months ago | $4.92 | $1,032.52 | +3.3% |
| 1 year ago | $2.9 | $1,751.72 | +75.2% |
| All time (4.8y) ago | $16.76 | $303.1 | -69.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SOPH forecast.
Our base-case forecast reaches $10.00 around 2031.
Implied market cap at $10.00: $717.9M
The multi-year forecast shows a bullish trajectory from 2027 onward. 2027 is forecast at an average of $6.01, 2028 at $7.22, 2029 at $8.38, and 2030 at $8.91, with ROIs of 23.1%, 47.9%, 71.7%, and 82.5% respectively.
Beyond 2030, 2031 averages $9.40, 2032 $9.32, 2033 $9.89, 2034 $12.64, and 2035 $14.00, with ROIs of 92.6%, 91%, 102.7%, 159%, and 186.9% respectively. In 2040 the average is forecast at $18.22 with a ROI of 273.3%, and in 2050 the average is forecast at $37.32 with a ROI of 664.7%.
These figures are estimates, not guarantees, and should be viewed in the context of potential risks and market volatility. They illustrate a long-term bullish trajectory rather than a guaranteed outcome.
Tap a question to reveal the answer.
2030 min $6.52, avg $8.91, max $13.14; ROI 82.5%; sentiment BULLISH.
The 2026 forecast shows min $4.10, avg $4.88, max $6.71 with sentiment NEUTRAL and ROI 0%. From 2027 onward the forecast is BULLISH with higher averages and ROIs through 2050 (e.g., 2027 avg $6.01, ROI 23.1%; 2050 avg $37.32, ROI 664.7%).
2040 forecast shows avg $18.22, max $31.37, min $11.37 with ROI 273.3% and sentiment BULLISH. The max value includes levels above $20.
Current price $4.88; market cap $350.34M; rank 3362.
2027 min $4.74, avg $6.01, max $8.09; ROI 23.1%; sentiment BULLISH.
SOPHiA GENETICS SA Community Discussion
0Share your SOPHiA GENETICS SA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.